| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 10% | 0% | $1,641,628 | +$632,468 | 886,887 | +63% | Perceptive Advisors LLC | 30 Sep 2025 |
| Ikarian Capital, LLC | 10% | 0% | $1,308,164 | +$359,065 | 812,524 | +38% | Ikarian Capital, LLC | 31 Dec 2025 |
| ORBIMED ADVISORS LLC | 20% | $1,164,061 | 760,824 | ORBIMED ADVISORS LLC | 31 Dec 2024 | |||
| Adage Capital Management, L.P. | 9.1% | +89% | $1,175,300 | +$644,000 | 730,000 | +121% | Adage Capital Management, L.P. | 31 Dec 2025 |
| Squadron Capital Management LLC | 8.9% | +6.2% | $1,148,799 | +$197,289 | 713,540 | +21% | Squadron Master Fund LP | 31 Dec 2025 |
| Chernett Jorey | 6.8% | $668,220 | 543,268 | Chernett Jorey | 14 Jan 2026 | |||
| Ayrton Capital LLC | 4.3% | -56% | $552,125 | -$97,751 | 342,935 | -15% | Ayrton Capital LLC | 31 Dec 2025 |
| Alyeska Investment Group, L.P. | 9.9% | $462,446 | 302,252 | Alyeska Investment Group, L.P. | 31 Dec 2024 |
As of 31 Dec 2025, 21 institutional investors reported holding 3,418,588 shares of Traws Pharma, Inc. - Common stock, par value $.01 per share (TRAW). This represents 42% of the company’s total 8,133,373 outstanding shares.
The largest institutional shareholders of Traws Pharma, Inc. - Common stock, par value $.01 per share (TRAW) together control 42% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 9% | 730,000 | +121% | 0% | $824,900 |
| Squadron Capital Management LLC | 8.8% | 713,540 | 0% | 0.36% | $806,300 |
| Ikarian Capital, LLC | 8.3% | 678,142 | +2280% | 0.1% | $766,299 |
| ORBIMED ADVISORS LLC | 7.4% | 605,531 | 0% | 0.01% | $684,250 |
| BOOTHBAY FUND MANAGEMENT, LLC | 2.4% | 194,536 | 0.01% | $219,826 | |
| ADAR1 Capital Management, LLC | 1.9% | 154,431 | 0.01% | $174,507 | |
| VANGUARD GROUP INC | 1.1% | 87,259 | 0% | 0% | $98,603 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.76% | 61,653 | +42% | 0% | $69,668 |
| Seven Fleet Capital Management LP | 0.61% | 49,260 | 0% | 0.04% | $55,664 |
| XTX Topco Ltd | 0.52% | 42,210 | +294% | 0% | $47,697 |
| STATE STREET CORP | 0.32% | 25,802 | 0% | $29,156 | |
| CITADEL ADVISORS LLC | 0.31% | 24,819 | 0% | $28,045 | |
| TWO SIGMA INVESTMENTS, LP | 0.24% | 19,244 | -13% | 0% | $21,746 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.17% | 14,197 | 0% | $16,043 | |
| BlackRock, Inc. | 0.12% | 9,956 | 0% | 0% | $11,250 |
| UBS Group AG | 0.09% | 7,722 | +128600% | 0% | $8,726 |
| SBI Securities Co., Ltd. | 0% | 162 | 0% | 0% | $183 |
| BANK OF AMERICA CORP /DE/ | 0% | 113 | +11% | 0% | $128 |
| OSAIC HOLDINGS, INC. | 0% | 8 | 0% | $9 | |
| FMR LLC | 0% | 2 | 0% | 0% | $2 |
| CITIGROUP INC | 0% | 1 | -100% | 0% | $1 |
| Vestal Point Capital, LP | 0% | 0 | -100% | $0 | |
| Vermillion & White Wealth Management Group, LLC | 0% | 0 | -100% | $0 | |
| HRT FINANCIAL LP | 0% | 0 | -100% | $0 | |
| ASSETMARK, INC | 0% | 0 | -100% | $0 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 3,418,588 | $3,863,003 | +$1,409,923 | $1.13 | 21 |
| 2025 Q3 | 1,304,595 | $2,413,244 | +$101,966 | $1.85 | 18 |
| 2025 Q2 | 1,263,487 | $1,869,962 | -$1,075,287 | $1.48 | 19 |
| 2025 Q1 | 1,732,309 | $3,984,315 | +$1,207,345 | $2.30 | 18 |
| 2024 Q4 | 1,141,975 | $10,140,752 | +$4,400,867 | $8.88 | 17 |
| 2024 Q3 | 646,356 | $3,800,574 | +$3,742,033 | $5.88 | 10 |